Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics

Bioorg Med Chem. 2008 Aug 1;16(15):7311-20. doi: 10.1016/j.bmc.2008.06.025. Epub 2008 Jun 18.

Abstract

Pirenzepine (2) is one of the most selective muscarinic M(1) versus M(2) receptor antagonists known. A series of 2 analogs, in which the piperazyl moiety was replaced by a cis- and trans-cyclohexane-1,2-diamine (3-6) or a trans- and cis-perhydroquinoxaline rings (7 and 8) were prepared, with the aim to investigate the role of the piperazine ring of 2 in the interaction with the muscarinic receptors. The structural change leading to compounds 3-6 abolished in binding assays the muscarinic M(1)/M(2) selectivity of 2, due to an increased M(2) affinity. Rather, compounds 3-6 displayed a reversed selectivity showing more affinity at the muscarinic M(2) receptor than at all the other subtypes tested.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Cyclohexylamines / chemistry*
  • Gene Expression Regulation
  • Guinea Pigs
  • Heart Atria / drug effects
  • Humans
  • Male
  • Models, Molecular
  • Molecular Structure
  • Muscarinic Antagonists / chemistry*
  • Muscarinic Antagonists / pharmacology*
  • Muscle, Skeletal / metabolism
  • Pirenzepine / analogs & derivatives*
  • Pirenzepine / chemistry*
  • Pirenzepine / pharmacology
  • Protein Binding
  • Quinoxalines / chemistry*
  • Rabbits
  • Receptors, Muscarinic / metabolism
  • Structure-Activity Relationship
  • Vas Deferens / drug effects

Substances

  • Cyclohexylamines
  • Muscarinic Antagonists
  • Quinoxalines
  • Receptors, Muscarinic
  • Pirenzepine
  • 1,2-cyclohexanediamine